AD01 Follow up Extension Visit

Observational Follow-up Extension Study-visit to Evaluate Long-term Safety and Tolerability of Immunization With AFFITOPE AD01 Applied During AFFiRiS001 in Patients With Alzheimer's Disease

Patients who were vaccinated with AFFITOPE AD01 during AFFiRiS001 will undergo a long-term follow-up period to get more information regarding the safety profile of AFFITOPE AD01.

Inclusion Criteria:

• Written informed consent signed and dated by the patient or the patient's legal representative and the caregiver.
• Patients having participated in AFFiRiS 001 and AFF003 and having received ≥1 vaccination with AFFITOPE AD01
• Availability of a partner/caregiver knowing the patient

Exclusion Criteria:

• Patients having received no vaccination with AFFITOPE AD01
• History of questionable compliance to visit schedule